Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017)
{{output}}
Introduction: Since years, ligands blocking histamine H3 receptor (H3R) activity (antagonists/inverse agonists) are interesting targets in the search for new cures for CNS disorders. Intensive works done by academic and pharmaceu... ...
